Evidence map›Paper›PMID 41701281›Full record

ArticleJournal of biomolecular NMR2026

A fast and efficient strategy for the NMR assignment of Fab methyl groups.

Faustine Henot, Béatrice Vibert, Arthur Giraud, Sarra Dbira, Lionel Imbert, Adrien Favier, Peter Güntert, Séverine Clavier, Elodie Crublet, Camille Doyen and 2 more

Abstract read
In one paragraph

Article in Journal of biomolecular NMR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Faustine HenotUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), 71, Avenue des Martyrs, Grenoble, 38044, France. faustine.henot@sanofi.com.ORCID http://orcid.org/0000-0002-5269-8792
Béatrice VibertUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), 71, Avenue des Martyrs, Grenoble, 38044, France.ORCID http://orcid.org/0000-0002-3317-2963
Arthur GiraudUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), 71, Avenue des Martyrs, Grenoble, 38044, France.
Sarra DbiraUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), 71, Avenue des Martyrs, Grenoble, 38044, France.
Lionel ImbertUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), 71, Avenue des Martyrs, Grenoble, 38044, France.ORCID http://orcid.org/0009-0000-6848-7570
Adrien FavierUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), 71, Avenue des Martyrs, Grenoble, 38044, France.ORCID http://orcid.org/0000-0003-2511-2300
Peter GüntertInstitute of Biophysical Chemistry, Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-2911-7574
Séverine ClavierSanofi Research & Development, Vitry‑sur‑Seine, 94403, France.ORCID http://orcid.org/0000-0001-5938-2144
Elodie CrubletNMR-Bio, 225 Route de Bivan, L'Albenc, 38470, France.
Camille DoyenSanofi Research & Development, Vitry‑sur‑Seine, 94403, France.
Jérôme BoisbouvierUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale (IBS), 71, Avenue des Martyrs, Grenoble, 38044, France. jerome.boisbouvier@ibs.fr.ORCID http://orcid.org/0000-0003-3278-3639
Oriane FrancesSanofi Research & Development, Vitry‑sur‑Seine, 94403, France. oriane.frances@sanofi.com.ORCID http://orcid.org/0000-0002-5397-5317

Funding

Agence Nationale de la Recherche ANR-15-IDEX-02CEA/CNRS/UGA/SANOFI 22CUF10215/221024
6 · The paper itself

Abstract

Owing to their high specificity and therapeutic effectiveness, monoclonal antibodies (mAbs) have rapidly become one of the leading classes of biologic drugs used to treat critical illnesses. The antigen-binding fragment (Fab) of mAbs plays a key role in the antigen recognition, so its structural characterization is essential, as even a slight change to its Higher Order Structure (HOS) can impact the antibody's potency. Recently, 2D methyl NMR has been introduced as a powerful method to assess both the structure and integrity of therapeutic Fab fragments. However, the identification of methyl group resonances in NMR spectra remains rare since Fabs are large heterodimers of ~ 50 kDa. Here, we present the methyl group assignment of an IgG1 Fab produced in a cell-free system with an optimal isotope labelling. We first assigned 99% of the alanine, isoleucine, leucine, methionine, and valine methyl groups of the therapeutic Fab targeting LAMP1 antigen. Building on this assignment, we propose a "divide and conquer" strategy that exploits sequence identities to rapidly assign methyl groups of other IgG1 Fabs. We demonstrate that the assignment of the Fab's constant region can easily be transferred from one IgG1 to another and that the variable part of a new Fab can be assigned using smaller uniformly

Indexed as

Immunoglobulin Fab FragmentsNuclear Magnetic Resonance, BiomolecularAntibodies, MonoclonalImmunoglobulin GIsotope LabelingMethylationAntibodies, MonoclonalImmunoglobulin Fab FragmentsImmunoglobulin GCell-freeIgG1 FabIsotope labellingMethyl groupsNMR assignment

Identifiers

PMID41701281
PMCPMC12913254

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.